Why haven’t we cured cancer yet?
IET EngTalks: Future Science
Formerly known as
The Kelvin Lecture
4 May 2017 | IET London: Savoy Place
The impact of microbubbles
Despite a century of incredible breakthroughs, cancer patient survival rates are still quoted in terms of 3 or 5 years and the impact of new treatments is so varied.
Could we design, manufacture and deliver ‘stimuli-responsive’ particles directly to the target site?
Oxford University’s Professor Eleanor Stride believes we can. In this year’s first Future Science EngTalk, she’ll introduce her work with ‘microbubbles’, the challenges of new drug delivery strategies and their potential for improving treatment of major diseases such as cancer or stroke.
First up, introducing Eleanor, will be our 10-minute insight speaker, Dr Jack Kreindler.
Founder of The Centre for Health and Human Performance, this is a man who wants to bring Artificial Intelligence into medical practice
Professor Eleanor Stride
Professor at the Institute of Biomedical Engineering at Oxford University and budding entrepreneur, fascinated in systems which integrate medical imaging and therapy.
10 minute insight:
Dr Jack Kreindler
Doctor, technology entrepreneur, co-organiser of TEDx London and commentator on the future of life science and medicine.
- Showcasing the world’s very best science, engineering and technology innovators
- Fascinating, interactive events on hot scientific topics
- Featuring cutting-edge speakers, thinkers and doers
- For people and professionals concerned about the future of science
- Hosted by the world’s most multi-disciplinary professional engineering membership organisation
- Building on the IET’s Prestige Lectures, which have ignited debate for over a century
18:00 - Registration
18:30 - 10 minute insight
18:40 - IET EngTalks: Future Science
20:00 - Networking drinks and exhibition
21:00 - Close